Research advances of factors and mechanisms for therapeutic efficacy of rituximab for primary membranous nephropathy
Primary membranous nephropathy （PMN） is a kidney-specific autoimmune disease mediated by autoantibodies. Although rituximab （RTX） has been widely applied as a first-line treatment for PMN, 20%-40% patients are non-responsive to RTX. High disease activity, severe renal lesions and low RTX bioavailabi...
Zapisane w:
| Główni autorzy: | , |
|---|---|
| Format: | Artigo |
| Język: | Chinês |
| Wydane: |
Editorial Department of Journal of Clinical Nephrology
2024-09-01
|
| Seria: | Linchuang shenzangbing zazhi |
| Hasła przedmiotowe: | |
| Dostęp online: | http://www.lcszb.com/cn/article/doi/10.3969/j.issn.1671-2390.2024.09.010 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|